These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 21174626)

  • 1. Practical recommendations for pharmacogenomics-based prescription: 2010 ESF-UB Conference on Pharmacogenetics and Pharmacogenomics.
    Becquemont L; Alfirevic A; Amstutz U; Brauch H; Jacqz-Aigrain E; Laurent-Puig P; Molina MA; Niemi M; Schwab M; Somogyi AA; Thervet E; Maitland-van der Zee AH; van Kuilenburg AB; van Schaik RH; Verstuyft C; Wadelius M; Daly AK
    Pharmacogenomics; 2011 Jan; 12(1):113-24. PubMed ID: 21174626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics of adverse drug reactions: practical applications and perspectives.
    Becquemont L
    Pharmacogenomics; 2009 Jun; 10(6):961-9. PubMed ID: 19530963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perception of the usefulness of drug/gene pairs and barriers for pharmacogenomics in Latin America.
    Quinones LA; Lavanderos MA; Cayun JP; Garcia-Martin E; Agundez JA; Caceres DD; Roco AM; Morales JE; Herrera L; Encina G; Isaza CA; Redal MA; Larovere L; Soria NW; Eslava-Schmalbach J; Castaneda-Hernandez G; Lopez-Cortes A; Magno LA; Lopez M; Chiurillo MA; Rodeiro I; Castro de Guerra D; Teran E; Estevez-Carrizo F; Lares-Assef I
    Curr Drug Metab; 2014 Feb; 15(2):202-8. PubMed ID: 24524664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent developments and future directions for the use of pharmacogenomics in cardiovascular disease treatments.
    Berinstein E; Levy A
    Expert Opin Drug Metab Toxicol; 2017 Sep; 13(9):973-983. PubMed ID: 28792790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4th ESPT Conference: pharmacogenomics and personalized medicine - research progress and clinical implementation.
    Sipeky C; Llerena A; Manolopoulos VG; Pearson E; Mlakar V; Gozzo L; Simmaco M; Marchetti P; Re MD; Stankovic S; Meyer U; Cascorbi I; Ingelman-Sundberg M; Suarez-Kurtz G; Marc J; Katsila T; Paulmichl M; Nofziger C; Ansari M; Drago F; van Schaik RH
    Pharmacogenomics; 2019 Oct; 20(15):1063-1069. PubMed ID: 31588876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The contribution of pharmacogenetics to pharmacovigilance.
    Bondon-Guitton E; Despas F; Becquemont L
    Therapie; 2016 Apr; 71(2):223-8. PubMed ID: 27080842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations for pharmacogenetic testing in clinical practice guidelines in the US.
    Hertz DL; Bousman CA; McLeod HL; Monte AA; Voora D; Orlando LA; Crutchley RD; Brown B; Teeple W; Rogers S; Patel JN
    Am J Health Syst Pharm; 2024 Aug; 81(16):672-683. PubMed ID: 38652504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implementation of pharmacogenetics.
    García-González X; Cabaleiro T; Herrero MJ; McLeod H; López-Fernández LA
    Drug Metab Pers Ther; 2016 Mar; 31(1):9-16. PubMed ID: 26751902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics: from bench to byte--an update of guidelines.
    Swen JJ; Nijenhuis M; de Boer A; Grandia L; Maitland-van der Zee AH; Mulder H; Rongen GA; van Schaik RH; Schalekamp T; Touw DJ; van der Weide J; Wilffert B; Deneer VH; Guchelaar HJ
    Clin Pharmacol Ther; 2011 May; 89(5):662-73. PubMed ID: 21412232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics research and its clinical implementation in Thailand: Lessons learned from the resource-limited settings.
    Sukasem C; Jantararoungtong T; Koomdee N
    Drug Metab Pharmacokinet; 2021 Aug; 39():100399. PubMed ID: 34098253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6th Golden Helix Pharmacogenomics Day: pharmacogenomics and individualized therapy.
    Stojiljkovic M; Fazlagic A; Dokmanovic-Krivokapic L; Nikcevic G; Patrinos GP; Pavlovic S; Zukic B
    Hum Genomics; 2012 Sep; 6(1):19. PubMed ID: 23157848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitous Pharmacogenomics (U-PGx): The Time for Implementation is Now. An Horizon2020 Program to Drive Pharmacogenomics into Clinical Practice.
    Cecchin E; Roncato R; Guchelaar HJ; Toffoli G;
    Curr Pharm Biotechnol; 2017; 18(3):204-209. PubMed ID: 28044932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics and pharmacogenomics: practical applications in routine medical practice.
    Maitland-van der Zee AH; Alfirevic A
    Genome Med; 2010 Sep; 2(9):69. PubMed ID: 20860855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of pharmacogenetics: the University of Maryland Personalized Anti-platelet Pharmacogenetics Program.
    Shuldiner AR; Palmer K; Pakyz RE; Alestock TD; Maloney KA; O'Neill C; Bhatty S; Schub J; Overby CL; Horenstein RB; Pollin TI; Kelemen MD; Beitelshees AL; Robinson SW; Blitzer MG; McArdle PF; Brown L; Jeng LJ; Zhao RY; Ambulos N; Vesely MR
    Am J Med Genet C Semin Med Genet; 2014 Mar; 166C(1):76-84. PubMed ID: 24616408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacogenomics : a toolbox to improve drug prescription].
    Jaccard E; Redin C; Girardin F; Waeber G; Fellay J; Vollenweider P
    Rev Med Suisse; 2020 Nov; 16(716):2259-2263. PubMed ID: 33237643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics and pharmacogenomics as tools in cancer therapy.
    Rodríguez-Vicente AE; Lumbreras E; Hernández JM; Martín M; Calles A; Otín CL; Algarra SM; Páez D; Taron M
    Drug Metab Pers Ther; 2016 Mar; 31(1):25-34. PubMed ID: 26863347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision medicine for rheumatologists: lessons from the pharmacogenomics of azathioprine.
    Daniel LL; Dickson AL; Chung CP
    Clin Rheumatol; 2021 Jan; 40(1):65-73. PubMed ID: 32617765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unveiling the guidance heterogeneity for genome-informed drug treatment interventions among regulatory bodies and research consortia.
    Koutsilieri S; Tzioufa F; Sismanoglou DC; Patrinos GP
    Pharmacol Res; 2020 Mar; 153():104590. PubMed ID: 31830522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomics and personalized medicine in clinical practice.
    Manolopoulos VG; Dechairo B; Huriez A; Kühn A; Llerena A; van Schaik RH; Yeo KT; Ragia G; Siest G
    Pharmacogenomics; 2011 May; 12(5):597-610. PubMed ID: 21619425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [PHARMACOGENOMICS AND PERSONALIZED MEDICINE: TOWARDS A SYSTEMATIC GENOMIC SCREENING?].
    Dideberg V; Segers K; Koopmansch B; Lambert F; Bours V
    Rev Med Liege; 2015; 70(5-6):251-6. PubMed ID: 26285448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.